Do race-specific models explain disparities in treatments after acute myocardial infarction?

被引:17
|
作者
Jha, Ashish K.
Staiger, Douglas O.
Lucas, F. Lee
Chandra, Amitabh
机构
[1] Harvard Univ, Dept Hlth Policy & Management, Boston, MA 02115 USA
[2] Va Boston Healthcare Syst, Boston, MA USA
[3] Harvard Univ, John F Kennedy, Sch Govt, Cambridge, MA 02138 USA
[4] Dartmouth Coll Sch Med, Hanover, NH USA
[5] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA
[6] Maine Med Ctr, Ctr Outcomes Res & Evaluat, Portland, ME USA
关键词
D O I
10.1016/j.ahj.2007.02.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Racial differences in healthcare are well known, although some have challenged previous research where risk-adjustment assumed covariates affect whites and blacks equally. if incorrect, this assumption may misestimate disparities. We sought to determine whether clinical factors affect treatment decisions for blacks and whites equally. Methods We used data from the Cardiovascular Cooperative Project for 130709 white and 8286 black patients admitted with an acute myocardial infarction. We examined the rates of receipt of 6 treatments using conventional common-effects models, where covariates affect whites and blacks equally, and race-specific models, where the effect of each covariate can vary by race. Results The common-effects models showed that blacks were less likely to receive 5 of the 6 treatments (odds ratios 0.64-1.10). The race-specific models displayed nearly identical treatment disparities (odds ratios 0.65-1.07). We found no interaction effect, which systematically suggested the presence of race-specific effects. Conclusions Race-specific models yield nearly identical estimates of racial disparities to those obtained from conventional models. This suggests that clinical variables, such as hypertension or diabetes, seem to affect treatment decisions equally for whites and blacks. Previously described racial disparities in care are unlikely to be an artifact of misspecified models.
引用
收藏
页码:785 / 791
页数:7
相关论文
共 50 条
  • [21] Race-specific trends in HPV vaccinations and provider recommendations: persistent disparities or social progress?
    Burdette, Amy M.
    Webb, Noah S.
    Hill, Terrence D.
    Jokinen-Gordon, Hanna
    PUBLIC HEALTH, 2017, 142 : 167 - 176
  • [22] Sex-Specific Disparities in the Management of Cardiogenic Shock Secondary to Acute Myocardial Infarction
    Gareja, Neha
    Ahmad, Mahmood
    JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (11) : 1184 - 1185
  • [23] Race and ethnicity in public health research: Models to explain health disparities
    Dressler, WW
    Oths, KS
    Gravlee, CC
    ANNUAL REVIEW OF ANTHROPOLOGY, 2005, 34 : 231 - 252
  • [24] Race, race, and mortality among veterans with acute myocardial infarction
    Lowy, Elliott
    Greiner, Gwen
    Sales, Anne
    Maynard, Chuck
    Fihn, Stephan
    CIRCULATION, 2006, 113 (21) : E819 - E820
  • [25] ACUTE MYOCARDIAL-INFARCTION - THE RACE TO THE HOSPITAL
    WEHRMACHER, WH
    POSTGRADUATE MEDICINE, 1989, 85 (02) : 112 - &
  • [26] THE TREATMENTS FOR MYOCARDIAL-INFARCTION IN ACUTE PHASE
    KANMATSUSE, K
    KODAMA, K
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1992, 56 : 1403 - 1405
  • [27] Immunosuppressive Treatments in Acute Myocardial Infarction and Stroke
    Raffaghello, Lizzia
    Bianchi, Giovanna
    Pistoia, Vito
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2012, 13 (01) : 59 - 67
  • [28] Trends in Acute Myocardial Infarction by Race and Ethnicity
    Chi, Gloria C.
    Kanter, Michael H.
    Li, Bonnie H.
    Qian, Lei
    Reading, Stephanie R.
    Harrison, Teresa N.
    Jacobsen, Steven J.
    Scott, Ronald D.
    Cavendish, Jeffrey J.
    Lawrence, Jean M.
    Tartof, Sara Y.
    Reynolds, Kristi
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (05):
  • [29] Do we need race-specific resting metabolic rate prediction equations?
    Reneau, James
    Obi, Brittaney
    Moosreiner, Andrea
    Kidambi, Srividya
    NUTRITION & DIABETES, 2019, 9 (1)
  • [30] Evidence-Based Treatments and Prescription Variability after Acute Myocardial Infarction
    Marco Bobbio
    Massimo Imazio
    Massimo Tidu
    Clinical Drug Investigation, 1999, 17 : 241 - 250